[
    {
        "id": 1,
        "category": "Strategic - Whitespace Analysis",
        "query": "Which respiratory diseases show low competition but high patient burden in India?",
        "expected_intent": "market_analysis",
        "complexity": "High"
    },
    {
        "id": 2,
        "category": "Strategic - Repurposing",
        "query": "Identify potential repurposing opportunities for Pembrolizumab beyond its current indications.",
        "expected_intent": "innovation_search",
        "complexity": "High"
    },
    {
        "id": 3,
        "category": "Tactical - Patent Check",
        "query": "When does the composition of matter patent for Sitagliptin expire in the US?",
        "expected_intent": "patent_search",
        "complexity": "Low"
    },
    {
        "id": 4,
        "category": "Tactical - Clinical Landscape",
        "query": "List all Phase III trials for Rivaroxaban competitors in Atrial Fibrillation.",
        "expected_intent": "clinical_search",
        "complexity": "Medium"
    },
    {
        "id": 5,
        "category": "Clarification / Follow-up",
        "query": "Do you want this by region or MoA?",
        "context": "User asked for 'competitor landscape'",
        "type": "system_clarification"
    },
    {
        "id": 6,
        "category": "Non-linear Input",
        "query": "Also check for biosimilar competition.",
        "context": "User previously asked about market size",
        "type": "refinement"
    },
    {
        "id": 7,
        "category": "Strategic - Market Entry",
        "query": "Evaluate the feasibility of launching a generic version of Apixaban in Brazil considering patent barriers.",
        "expected_intent": "feasibility_study",
        "complexity": "High"
    },
    {
        "id": 8,
        "category": "Scientific - Guidelines",
        "query": "What are the latest FDA guidelines for biosimilar interchangeability?",
        "expected_intent": "web_search",
        "complexity": "Medium"
    },
    {
        "id": 9,
        "category": "Internal Knowledge",
        "query": "Summarize our internal strategy for the diabetes portfolio in 2025.",
        "expected_intent": "internal_rag",
        "complexity": "Medium"
    },
    {
        "id": 10,
        "category": "Complex - Multi-agent",
        "query": "Find me a molecule with high import volume in India, expired patents, and growing market demand.",
        "expected_intent": "multi_agent_synthesis",
        "complexity": "Very High"
    }
]